635.2000 2.55 (0.40%)
NSE Sep 01, 2026 10:05 AM
Volume: 98,925
 

635.20
0.40%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Number of FII/FPI investors increased from 66 to 74 in Jun 2026 qtr.
More from Solara Active Pharma Sciences Ltd.
Recommended